Srivastava K C, Awasthi K K
Prostaglandins Leukot Med. 1983 Apr;10(4):411-21. doi: 10.1016/0262-1746(83)90053-7.
Effects of some vasodilating (dipyridamole, nifedipine and verapamil) and antihypertensive (propranolol, hydralazine) drugs on arachidonic acid metabolism in isolated rat aorta and lung have been studied. Dipyridamole significantly increased the formation of PGI2 in aorta and lung. Nifedipine and verapamil decreased the formation of PGI2 in aorta, these drugs though significantly increased the formation of PGI2 in lung. Nifedipine showed no appreciable effect on the generation of TxA2 in rat aorta but in lung both nifedipine and verapamil reduced TxA2 formation though significantly only in the latter case. Dipyridamole showed no effect. The beneficial effect of dipyridamole, seems, at least in part, to be due to its ability to enhance the production of PGI2 both in the aorta and lung, and probably in other tissues as well. Nifedipine and verapamil may show their antianginal effect by a combined effect of enhanced PGI2 and reduced TxA2 formation in lung. In lung, whereas hydralazine reduced the formation of both PGI2 and TxA2, propranolol increased the formation of PGI2. Hydralazine reduced the formation of TxA2 and increased PGI2 formation in aorta. The effect of the drugs on the ability of rat aorta to inhibit collagen induced platelet aggregation of human blood platelets was also examined.
研究了一些血管舒张药物(双嘧达莫、硝苯地平和维拉帕米)和抗高血压药物(普萘洛尔、肼屈嗪)对离体大鼠主动脉和肺中花生四烯酸代谢的影响。双嘧达莫显著增加主动脉和肺中前列环素(PGI2)的生成。硝苯地平和维拉帕米降低主动脉中PGI2的生成,不过这两种药物显著增加肺中PGI2的生成。硝苯地平对大鼠主动脉中血栓素A2(TxA2)的生成无明显影响,但在肺中,硝苯地平和维拉帕米均降低TxA2的生成,不过仅在后一种情况下有显著降低。双嘧达莫无此作用。双嘧达莫的有益作用似乎至少部分归因于其增强主动脉和肺中以及可能其他组织中PGI2生成的能力。硝苯地平和维拉帕米可能通过增强肺中PGI2生成和降低TxA2生成的联合作用而发挥抗心绞痛作用。在肺中,肼屈嗪降低PGI2和TxA2的生成,而普萘洛尔增加PGI2的生成。肼屈嗪降低主动脉中TxA2的生成并增加PGI2的生成。还研究了这些药物对大鼠主动脉抑制胶原诱导的人血小板聚集能力的影响。